# Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.

> **NCT04622917** · PHASE4 · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 44 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal
- Hay Fever
- Pollen Allergy
- Allergic Rhinitis

## Interventions

- **DRUG:** MethylPREDNISolone 40 Mg/mL Injectable Suspension
- **DRUG:** NaCl 9 MG/ML Injectable Solution

## Key facts

- **NCT ID:** NCT04622917
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-10
- **Primary completion:** 2022-06-20
- **Final completion:** 2023-05-31
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04622917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04622917, "Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04622917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*